articleThe Lancet OncologyJul 15, 2013Closed access

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

SPSant P. ChawlaRMRobert M. HenshawLLLeanne L. SeegerECEdwin ChoyJBJean‐Yves Blay

Sarcoma Oncology Center · Washington Hospital · +17 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

580
total citations
FWCI
32.86
Percentile
100%
References
24
Citations per year

Authors

16

Topics & keywords

Topics
Keywords
  • Denosumab
  • Interim analysis
  • Interim
  • Medicine
  • Oncology
  • Internal medicine
  • Osteoporosis
  • Clinical trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding